Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vivek Ramaswamy
Vivek Ramaswamy
Vivek Ramaswamy exits presidential race after Iowa result
Pharmaphorum
Tue, 01/16/24 - 09:01 am
2024 Presidential election
Vivek Ramaswamy
Donald Trump
Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech
Stat
Thu, 08/24/23 - 10:25 am
Vivek Ramaswamy
2024 Presidential election
biotech
Roivant
Vivek Ramaswamy wants to ‘gut’ the FDA
Stat
Mon, 07/31/23 - 09:48 pm
Vivek Ramaswamy
2024 Presidential election
FDA
Roivant Sciences
How Vivek Ramaswamy helped make Martin Shkreli the ‘pharma bro’
Politico
Wed, 05/24/23 - 10:26 am
Vivek Ramaswamy
Martin Shkreli
Biotech entrepreneur Vivek Ramaswamy launched his 2024 GOP presidential bid
Yahoo Finance
Wed, 02/22/23 - 10:05 am
Vivek Ramaswamy
Roivant
2024 Presidential election
Biotech leader and ex-CEO of Roivant Sciences Ramaswamy may consider running for president as a Republican
Politico
Tue, 02/14/23 - 10:37 am
2024 Presidential election
Vivek Ramaswamy
Roivant Sciences
An FDA mistake signals likely approval for Vivek Ramaswamy’s first therapy for children born without a thymus
Endpoints
Fri, 10/1/21 - 10:50 am
Enzyvant
Vivek Ramaswamy
FDA
congenital athymia
Roivant’s move to go public reveals just how much its drug strategy has changed
MedCity News
Tue, 05/4/21 - 10:39 pm
Roivant Sciences
Vivek Ramaswamy
Vivek Ramaswamy's LNP delivery tech play Genevant scores $600M licensing deal from Takeda for nucleic acid therapies
Endpoints
Mon, 03/15/21 - 11:10 am
Vivek Ramaswamy
Genevant
lipid nanoparticles
Takeda
Roivant Sciences founder to step down as CEO
Reuters
Mon, 01/25/21 - 11:10 am
Roivant
Phamra CEOs
Vivek Ramaswamy
Vivek Ramaswamy’s Metavant hits a brick wall, abandoning a lead program for diabetes. And there’s nothing visible left to see here
Endpoints
Fri, 11/20/20 - 11:20 am
Metavant
diabetes
Vivek Ramaswamy
imeglimin
On Heels of the Sale of Five Vants, Roivant Launches New Company Lokavant
BioSpace
Mon, 01/13/20 - 11:46 pm
Roivant
Vivek Ramaswamy
clinical trials
Lokavant
The Roivant-Sumitomo Deal: $3 Billion, 5 Companies, $550 Million in Loans and an Option on 6 More...
BioSpace
Fri, 11/1/19 - 06:57 pm
M&A
Roivant
Vivek Ramaswamy
Sumitomo Dainippon
Vivek Ramaswamy trades top execs and adds stealthy vant to $3B sale, while his new partner tosses Myovant $350M
Endpoints
Thu, 10/31/19 - 10:50 am
Vivek Ramaswamy
Sumitomo Dainippon
Myovant
Two acute cases of liver disease in healthy subjects kill Arbutus' hep B program
Endpoints
Fri, 10/4/19 - 10:32 am
Arbutus BioPharma
hepatitis B
clinical trials
Vivek Ramaswamy
AB-506
Ramaswamy's Dermavant Updates $124 Million IPO Filing
CP Wire
Mon, 06/10/19 - 09:53 am
Dermavant
IPOs
tapinarof
psoriasis
dermatitis
Vivek Ramaswamy
Vivek Ramaswamy’s Urovant claims a big win in PhIII — but questions linger about a cheap generic and their branded rival
Endpoints
Tue, 03/19/19 - 10:30 am
Axovant
Alzheimer's disease
Roivant
Vivek Ramaswamy
Urovant
vibegron
urinary incontinence
A New Day, a New Vant. Roivant Launches Alyvant Ahead of J.P. Morgan 2019
BioSpace
Mon, 01/7/19 - 12:24 pm
Vivek Ramaswamy
Roivant
Alyvant
JPMHC 2019
Vivek Ramaswamy strikes again, this time launching a Beijing-based biotech player with a pipeline
Endpoints
Tue, 07/17/18 - 10:16 am
Vivek Ramaswamy
Roivant
China
Sinovant
Roivant CEO: Yes, we failed in Alzheimer’s, but we’re not giving up
Fierce Biotech
Sat, 11/11/17 - 11:04 am
Roivant
Alzheimer's disease
Vivek Ramaswamy
Pages
1
2
next ›
last »